F - 5
F - 6
F - 7
F - 8
F - 9
F - 10
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
F - 11
F - 12
NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
F - 13
F - 14
F - 15
F - 16
F - 17
F - 18
F - 19
F - 20
F - 21
F - 22
F - 23
F - 24
F - 25
F - 26
F - 27
F - 28
F - 29
F - 30
F - 31
F - 32
F - 33
Amortization of net gain
Total recognized in net periodic benefit cost and other comprehensive income
Year the ultimate rate is reached (pre-65/post-65)
December 31, 2023
F - 34
Actuarial gain, net
F - 35
Year the ultimate rate is reached (pre-65/post-65 Non-Medicare Advantage)
2033/2033
2031/2031
F - 36
Total recognized loss (gain) in other comprehensive income =
Total recognized in net periodic benefit cost (gain) and other comprehensive income
F - 37
F - 38
F - 39
F - 40
NOTE 14: COMMITMENTS AND CONTINGENCIES (continued)
F - 41
NOTE 15: SHAREHOLDERS’ EQUITY
F - 42
NOTE 15: SHAREHOLDERS’ EQUITY (continued)
F - 43
F - 44
F - 45
F - 46
F - 47
F - 48
F - 49
F - 50
F - 51
F - 52